GlassScriptPhysician profile
Heather M Gulish
NPI 1679538318
$9,556.41
in general payments reported to CMS, 2019-2025
32 companies · $1,866 in 2025
The $1,866 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $579 · 2022: $749 · 2023: $2,598 · 2024: $3,764 · 2025: $1,866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,773 · Travel and Lodging: $2,212 · Education: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,772.56 |
| Travel and Lodging | $2,212.00 |
| Education | $243.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,258.82 | 2021-2025 | Interstim |
| Astrazeneca Pharmaceuticals LP | $612.09 | 2022-2025 | Lynparza |
| Sumitomo Pharma America, INC. | $607.30 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $521.99 | 2022-2025 | Erleada, Carvykti, Rybrevant |
| Merck Sharp & Dohme LLC | $442.91 | 2022-2025 | Keytruda, Welireg, Lynparza |
| Endo USA, INC. | $319.11 | 2024-2025 | Xiaflex |
| Abbvie INC. | $311.67 | 2022-2025 | |
| Coloplast Corp | $290.30 | 2023-2024 | Speedicath |
| Pfizer INC. | $283.39 | 2023-2025 | |
| Myriad Genetic Laboratories, INC. | $270.23 | 2021-2023 | Myrisk, Prolaris |
| Antares Pharma, INC. | $231.32 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Astellas Pharma US INC | $224.33 | 2021-2024 | Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $223.70 | 2023-2025 | |
| Endo Pharmaceuticals INC. | $213.90 | 2021-2024 | Xiaflex |
| Dendreon Pharmaceuticals LLC | $209.29 | 2023-2025 | Provenge |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $206.78 | 2023 | |
| Urogen Pharma, INC. | $188.40 | 2022-2025 | Jelmyto |
| Allergan, INC. | $150.95 | 2021-2022 | |
| Olympus America INC. | $145.62 | 2025 | Itind System |
| Procept Biorobotics Corporation | $140.94 | 2024-2025 | Aquabeam System |
| Axonics, INC. | $139.91 | 2021-2024 | Bulkamid, Axonics |
| Verity Pharmaceuticals INC. | $87.09 | 2024-2025 | Tlando |
| 180 Medical, INC. | $74.02 | 2022-2024 | |
| Tolmar, INC. | $72.23 | 2023-2025 | Jatenzo, Eligard |
| Clarus Therapeutics INC. | $61.77 | 2021 | |
| Immunitybio, INC. | $59.02 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $58.42 | 2025 | Adstiladrin |
| Boston Scientific Corporation | $49.41 | 2023 | Rezum Generator |
| Ambu INC. | $36.00 | 2023 | |
| Urovant Sciences INC | $27.81 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $18.91 | 2022 | |
| Calyxo, INC. | $18.78 | 2024 | Cvac Aspiration System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Gulish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.